ENDRA Life Sciences Shares Are Trading Higher After the Company Announced the Activation of a Post Market Clinical Study of the TAEUS Liver System.
ENDRA Life Sciences Shares Are Trading Higher After the Company Announced the Activation of a Post Market Clinical Study of the TAEUS Liver System.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.